(0.16%) 5 163.00 points
(0.13%) 38 881 points
(0.12%) 18 022 points
(0.92%) $78.83
(0.47%) $2.15
(0.97%) $2 331.00
(2.59%) $27.38
(0.52%) $970.30
(0.02%) $0.929
(-0.28%) $10.84
(-0.19%) $0.796
(0.15%) $91.59
0.00% SEK 0.121
Live Chart Being Loaded With Signals
Idogen AB (publ), a biotechnology company, develops tolerogenic cell therapies to prevent the patient's immune system from attacking biological agents, transplanted organs, and the body's own cells or tissues in Sweden...
Stats | |
---|---|
Volumen de hoy | 1.13M |
Volumen promedio | 0.00 |
Capitalización de mercado | 12.79M |
EPS | SEK-0.0727 ( 2023-05-09 ) |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -0.320 |
ATR14 | SEK0.0520 (43.15%) |
Volumen Correlación
Idogen AB (publ) Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Idogen AB (publ) Correlación - Moneda/Commodity
Idogen AB (publ) Finanzas
Annual | 2022 |
Ingresos: | SEK0 |
Beneficio Bruto: | SEK0 (0.00 %) |
EPS: | SEK-0.760 |
FY | 2022 |
Ingresos: | SEK0 |
Beneficio Bruto: | SEK0 (0.00 %) |
EPS: | SEK-0.760 |
FY | 2021 |
Ingresos: | SEK0.00 |
Beneficio Bruto: | SEK0.00 (0.00 %) |
EPS: | SEK-1.699 |
FY | 2020 |
Ingresos: | SEK0.00 |
Beneficio Bruto: | SEK0.00 (0.00 %) |
EPS: | SEK-3.32 |
Financial Reports:
No articles found.
Idogen AB (publ)
Idogen AB (publ), a biotechnology company, develops tolerogenic cell therapies to prevent the patient's immune system from attacking biological agents, transplanted organs, and the body's own cells or tissues in Sweden. The company's advanced product candidate is IDO 8 that is designed for patients with severe haemophilia A, who have developed neutralizing antibodies against critical treatment with coagulation factor VIII. It also develops IDO T, a tolerogenic cell therapy to prevent organ transplant rejection primarily kidney transplantation; and IDO AID for the treatment of autoimmune diseases. The company was incorporated in 2008 and is headquartered in Lund, Sweden.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico